| abstract |
The present invention, for example, relates to a polypeptide consisting of an amino acid sequence selected from the group consisting of: (a) the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 8; (b) by 1 and a malaria vaccine comprising the same An amino acid sequence that differs from the amino acid sequence of SEQ ID NO:4 or SEQ ID NO:8 by substitution, deletion, addition or insertion of ~10, preferably 1 to 5, more preferably 1, 2 or 3 amino acids; and ( c) an amino acid sequence having at least 95%, preferably 97%, more preferably 99% sequence identity to the amino acid sequence of SEQ ID NO:4 or SEQ ID NO:8. |